Literature DB >> 17667817

Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.

Marit Saethre1, Bettina C Baumann, Michael Fung, Jörg D Seebach, Tom Eirik Mollnes.   

Abstract

BACKGROUND: The generation of Galalpha1-3Gal (Gal) transferase deficient pigs has increased the interest in non-Gal antigens potentially representing important targets for xenoreactive antibody binding leading to xenograft rejection. The present study addressed the levels and immunoglobulin isotypes of preformed human anti-non-Gal antibodies and their potential to activate porcine endothelial cells.
METHODS: Porcine endothelial cells lacking the Gal epitope (Gal-/-) were used to measure immunoglobulin (Ig) M and IgG subclass anti-non-Gal antibodies, using sera from 80 blood donors and pooled human AB serum. Antibodies specific for the non-Gal Hanganutziu-Deicher (HD) xenoantigen were measured by enzyme-linked immunosorbent assay. Activation of Gal-/- and Gal+/+ endothelial cells by human serum was measured, in the presence or absence of complement inhibitors, by E-selectin cell-surface expression using flow cytometry.
RESULTS: Anti-non-Gal antibody levels varied considerably among individual sera and comprised approximately 10% of total anti-porcine antibodies without sex or age differences. Among the IgG subclasses only IgG1 and IgG2 were detected. Human serum-induced E-selectin expression on Gal-/- cells was less than 20% compared with Gal+/+ cells, correlated with anti-HD IgM and IgG antibody levels (P=0.027 and 0.032, respectively), and was largely complement-independent in accordance with the lack of IgG3 anti-non-Gal antibodies. In contrast, E-selectin upregulation on Gal+/+ cells was reduced in complement blocking experiments.
CONCLUSION: Preformed anti-non-Gal antibodies, in particular anti-HD antibodies, were present in all human sera samples, activated porcine endothelial cells, and may therefore play a role in xenograft rejection using organs from GalT-/- pigs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667817     DOI: 10.1097/01.tp.0000268815.90675.d5

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  23 in total

1.  Identification of the tetraspanin CD82 as a new barrier to xenotransplantation.

Authors:  Soad M Saleh; Ranjit S Parhar; Reem S Al-Hejailan; Razan H Bakheet; Hala S Khaleel; Hanif G Khalak; Anason S Halees; Marya Z Zaidi; Brian F Meyer; Gisella P Yung; Jörg D Seebach; Walter Conca; Khalid S Khabar; Kate S Collison; Futwan A Al-Mohanna
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

2.  Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model.

Authors:  Laura Higginbotham; Dave Mathews; Cynthia A Breeden; Mingqing Song; Alton Brad Farris; Christian P Larsen; Mandy L Ford; Andrew J Lutz; Matthew Tector; Kenneth A Newell; A Joseph Tector; Andrew B Adams
Journal:  Xenotransplantation       Date:  2015-04-03       Impact factor: 3.907

3.  Reducing the Threshold for Clinical Renal Xenotransplantation.

Authors:  Peter J Cowan; Francesco L Ierino
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

4.  Trial using pig cells with the H-D antigen knocked down.

Authors:  Aki Yamamoto; Kosuke Ikeda; Dandan Wang; Shino Nakatsu; Yuichi Takama; Takehisa Ueno; Hiroshi Nagashima; Akihiro Kondo; Masahiro Fukuzawa; Shuji Miyagawa
Journal:  Surg Today       Date:  2012-08-05       Impact factor: 2.549

5.  Human immune reactivity against liver sinusoidal endothelial cells from GalTα(1,3)GalT-deficient pigs.

Authors:  Daan van Poll; Yakoov Nahmias; Alejandro Soto-Gutierrez; Mitra Ghasemi; Hiroshi Yagi; Naoya Kobayashi; Martin L Yarmush; Martin Hertl
Journal:  Cell Transplant       Date:  2010-06-23       Impact factor: 4.064

6.  Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts.

Authors:  Christopher G A McGregor; Davide Ricci; Naoto Miyagi; Paul G Stalboerger; Zeji Du; Elise A Oehler; Henry D Tazelaar; Guerard W Byrne
Journal:  Transplantation       Date:  2012-04-15       Impact factor: 4.939

7.  The anti-non-gal xenoantibody response to xenoantigens on gal knockout pig cells is encoded by a restricted number of germline progenitors.

Authors:  K Kiernan; I Harnden; M Gunthart; C Gregory; J Meisner; M Kearns-Jonker
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

8.  Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cells.

Authors:  Agnes M Azimzadeh; Guerard W Byrne; Mohamed Ezzelarab; Emily Welty; Gheorghe Braileanu; Xiangfei Cheng; Simon C Robson; Christopher G A McGregor; David K C Cooper; Richard N Pierson
Journal:  Xenotransplantation       Date:  2014-09-01       Impact factor: 3.907

9.  Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.

Authors:  Eliran Moshe Reuven; Shani Leviatan Ben-Arye; Tal Marshanski; Michael E Breimer; Hai Yu; Imen Fellah-Hebia; Jean-Christian Roussel; Cristina Costa; Manuel Galiñanes; Rafael Mañez; Thierry Le Tourneau; Jean-Paul Soulillou; Emanuele Cozzi; Xi Chen; Vered Padler-Karavani
Journal:  Xenotransplantation       Date:  2016-09-09       Impact factor: 3.907

10.  Cytokine secretion depends on Galalpha(1,3)Gal expression in a pig-to-human whole blood model.

Authors:  Marit Saethre; Mårten K J Schneider; John D Lambris; Paola Magotti; Guttorm Haraldsen; Jörg D Seebach; Tom E Mollnes
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.